<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Etomidate: Drug information</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Etomidate: Drug information</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="drugTitle">Etomidate: Drug information</div><div class="clear"></div><div id="topicText">(For additional information <a class="drug drug_patient" data-topicid="12170" href="/d/html/12170.html" rel="external">see "Etomidate: Patient drug information"</a> and <a class="drug drug_pediatric" data-topicid="12907" href="/d/html/12907.html" rel="external">see "Etomidate: Pediatric drug information"</a>)<br/><br/>For abbreviations, symbols, and age group definitions used in Lexicomp (<a class="graphic graphic_table" href="/d/html/57469.html" rel="external">show table</a>)<div class="visuallyHidden drugH1Div" id="formulinkBodyPlaceholder"><span class="drugH1"></span></div>
<div class="list ubnlist drugH1Div drugBrandNames" id="F169136"><span class="drugH1">Brand Names: US</span>
<ul>
<li>Amidate</li></ul></div>
<div class="list canbnlist drugH1Div drugBrandNames" id="F58246182"><span class="drugH1">Brand Names: Canada</span>
<ul>
<li>Tomvi</li></ul></div>
<div class="ex_sect_xr thclist drugH1Div drugBrandNames" id="F169163"><span class="drugH1">Pharmacologic Category</span>
<ul>
<li>
                        Cortisol Synthesis Inhibitor;</li>
<li>
                        General Anesthetic</li></ul></div>
<div class="block doa drugH1Div" id="F169139"><span class="drugH1">Dosing: Adult</span>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="fd1ec529-f0cc-4b8f-b590-e6aa834a8769">Cushing syndrome</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Cushing syndrome (off-label use): Note:</b> Studies have not reported sedation at these etomidate doses; however, patients should be managed in an intensive care unit with sedation scoring every 2 hours initially for the first 24 hours, then every 12 hours. Cortisol levels should be measured every 4 to 6 hours (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-26222757','lexi-content-ref-22577107']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-26222757','lexi-content-ref-22577107'])">Ref</a></span>). Optimal regimen and doses have not been identified; refer to institutional protocols.</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>IV:</b> Initial: 3 to 5 mg loading dose, followed by 0.02 to 0.05 mg/<b>kg</b>/hour continuous IV infusion (usually equates to 1.5 to 4 mg/hour). Titrate to serum cortisol of 18 to 29 mcg/dL (500 to 800 nmol/L) in a physiologically stressed patient <b>or</b> 5.5 to 11 mcg/dL (150 to 300 nmol/L) in a nonphysiologically stressed patient. For complete blockade, titrate infusion rate to achieve a cortisol level &lt;5.5 mcg/dL (&lt;150 nmol/L). Hydrocortisone IV is required if complete blockade desired rather than partial blockade (‘block and replace’) (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-30560224','lexi-content-ref-26222757','lexi-content-ref-22577107']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-30560224','lexi-content-ref-26222757','lexi-content-ref-22577107'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="d181a5f4-ff4e-4c53-9710-1ef232f62b7c">General anesthesia</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>General anesthesia: IV: </b>Initial: 0.3 mg/kg over 30 to 60 seconds for induction of anesthesia; usual dosage range: 0.2 to 0.6 mg/kg.</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="e957755b-7e6a-4c47-abc7-399e245a30c5">Procedural sedation</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Procedural sedation (off-label use):</b>
<b>IV:</b> Initial: 0.1 to 0.2 mg/kg, followed by 0.05 mg/kg every 3 to 5 minutes as needed (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-15829394','lexi-content-ref-16997421','lexi-content-ref-12023700']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-15829394','lexi-content-ref-16997421','lexi-content-ref-12023700'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="16f9dccd-d560-4631-83e4-036a7dc3f121">Rapid sequence intubation outside the operating room</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Rapid sequence intubation outside the operating room (induction):</b>
<b>Note:</b> Provides no analgesic effects (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-37196592']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-37196592'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>IV:</b> Initial: 0.3 mg/kg; usual dosage range: 0.2 to 0.3 mg/kg (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-19573904','lexi-content-ref-37248552','lexi-content-ref-34904190','lexi-content-ref-37076524','lexi-content-ref-34535237','lexi-content-ref-27993308']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-19573904','lexi-content-ref-37248552','lexi-content-ref-34904190','lexi-content-ref-37076524','lexi-content-ref-34535237','lexi-content-ref-27993308'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="0664e694-f1d6-4b33-ad10-b45bf7f031b7">Supplementation to subpotent anesthetic agents</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Supplementation to subpotent anesthetic agents:</b>
<b>IV:</b> Administer smaller increments during short operative procedures to supplement subpotent anesthetic agents, such as nitrous oxide; individualize dosage (usually smaller than the original induction dose).</p></div>
</div>
</div>
<div class="block dora drugH1Div" id="F50991516"><span class="drugH1">Dosing: Kidney Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling; use with caution, risk of toxicity is greater in patients with renal impairment.</p></div>
<div class="block doha drugH1Div" id="F50988891"><span class="drugH1">Dosing: Hepatic Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block doo drugH1Div" id="F56702067"><span class="drugH1">Dosing: Obesity: Adult</span>
<p style="text-indent:0em;display:inline">The recommendations for dosing in patients with obesity are based upon the best available evidence and clinical expertise. Senior Editorial Team: Jeffrey F. Barletta, PharmD, FCCM; Manjunath P. Pai, PharmD, FCP; Jason A. Roberts, PhD, BPharm (Hons), B App Sc, FSHP, FISAC.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>Class 1 and 2 obesity (BMI 30 to 39 kg/m<sup>2</sup>): IV:</b> Use <b>actual body weight</b> for weight-based dose calculations (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-32513237']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-32513237'])">Ref</a></span>). Refer to adult dosing for indication-specific doses.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>Class 3 obesity (BMI ≥</b>
<b>40 kg/m<sup>2</sup>): IV: </b>Use <b>adjusted body weight</b> for weight-based dose calculations (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-32513237']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-32513237'])">Ref</a></span>). Refer to adult dosing for indication-specific doses.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>Rationale for recommendations:</b> Etomidate has a large V<sub>d</sub> (2.5 to 4.5 L/kg) with peak anesthetic effects occurring within minutes and a rapid loss of effect related to redistribution (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-20498288','lexi-content-ref-Expert.DOO']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-20498288','lexi-content-ref-Expert.DOO'])">Ref</a></span>). In 1 study evaluating patients with a BMI ≥40 kg/m<sup>2</sup>, the total dose required to achieve sedation was similar between the observed dose and ideal body weight predicted dose or adjusted body weight predicted dose. The adjusted body weight predicted dose was slightly higher than the observed dose (26.8 vs 21.7 mg) (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-25101716']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-25101716'])">Ref</a></span>). Given that the risk of underdosing (eg, awake while paralyzed) outweighs the risk of toxicity, use actual body weight in patients with a BMI 30 to 39 kg/m<sup>2</sup> and consider adjusted body weight in patients with a BMI ≥40 kg/m<sup>2</sup> (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-32513237']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-32513237'])">Ref</a></span>).</p></div>
<div class="block doe drugH1Div" id="F169140"><span class="drugH1">Dosing: Older Adult</span>
<p style="text-indent:0em;display:inline">Refer to adult dosing; reduced doses may be required.</p></div>
<div class="block dop drugH1Div" id="F169150"><span class="drugH1">Dosing: Pediatric</span><p>(For additional information <a class="drug drug_pediatric" data-topicid="12907" href="/d/html/12907.html" rel="external">see "Etomidate: Pediatric drug information"</a>)</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="e4d7feff-7572-41ef-abaf-e3d08bc84442">Anesthesia, induction</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Anesthesia, induction:</b></p>
<p style="text-indent:-2em;margin-left:4em;">Infants: Very limited data available: IV: 0.2 to 0.3 mg/kg/dose as a single dose; dosing based on a prospective, observational trial and two pharmacokinetic studies (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-1259886','lexi-content-ref-21917057','lexi-content-ref-25377074']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-1259886','lexi-content-ref-21917057','lexi-content-ref-25377074'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">Children &lt;10 years: Limited data available: IV: 0.2 to 0.3 mg/kg/dose as a single dose (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-26496368','lexi-content-ref-Ghazal.1','lexi-content-ref-32193044','lexi-content-ref-1259886']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-26496368','lexi-content-ref-Ghazal.1','lexi-content-ref-32193044','lexi-content-ref-1259886'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">Children ≥10 years and Adolescents: Usual dose: IV: 0.3 mg/kg/dose as a single dose; range: 0.2 to 0.6 mg/kg/dose.</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="e957755b-7e6a-4c47-abc7-399e245a30c5">Procedural sedation</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Procedural sedation: </b>Limited data available; dosing variable: Infants ≥6 months, Children, and Adolescents: IV: Usual initial dose: 0.2 to 0.3 mg/kg/dose prior to procedure (reported range: 0.1 to 0.4 mg/kg/dose); repeat doses may be needed depending on patient response and duration of the procedure; repeat doses vary in the literature and range from 0.1 to 0.2 mg/kg/dose; reported maximum total dose ranged from 0.3 to 0.6 mg/kg per procedure (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-18090099','lexi-content-ref-11136155','lexi-content-ref-16997680','lexi-content-ref-15295244','lexi-content-ref-20502386','lexi-content-ref-22929142','lexi-content-ref-26926332']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-18090099','lexi-content-ref-11136155','lexi-content-ref-16997680','lexi-content-ref-15295244','lexi-content-ref-20502386','lexi-content-ref-22929142','lexi-content-ref-26926332'])">Ref</a></span>). <b>Note</b>: Etomidate does <b>not</b> have analgesic properties; additional therapy (eg, fentanyl) may be needed for painful procedures (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-24438649']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-24438649'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="d3b65e73-c545-4638-adf8-ee69e12a052b">Rapid sequence intubation</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Rapid sequence intubation (RSI):</b> Limited data available; Infants, Children, and Adolescents: IV, Intraosseous: 0.2 to 0.4 mg/kg/dose as a single dose; maximum dose: 20 mg/dose (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Hazinski.1','lexi-content-ref-31871244']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Hazinski.1','lexi-content-ref-31871244'])">Ref</a></span>). <b>Note:</b> Not recommended for patients in septic shock due to an association between transient adrenocortical suppression and increased mortality rate (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-17710382','lexi-content-ref-20956230']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-17710382','lexi-content-ref-20956230'])">Ref</a></span>).</p></div>
</div>
</div>
<div class="block dorp drugH1Div" id="F51109924"><span class="drugH1">Dosing: Kidney Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling; use with caution, risk of toxicity is greater in patients with renal impairment.</p></div>
<div class="block dohp drugH1Div" id="F51109925"><span class="drugH1">Dosing: Hepatic Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block adr drugH1Div" id="F169113"><span class="drugH1">Adverse Reactions</span>
<p style="text-indent:0em;display:inline">The following adverse drug reactions and incidences are derived from product labeling unless otherwise specified.</p>
<p style="text-indent:-2em;margin-left:2em;">&gt;10%:</p>
<p style="text-indent:-2em;margin-left:4em;">Central nervous system: Myoclonus (33%)</p>
<p style="text-indent:-2em;margin-left:4em;">Endocrine &amp; metabolic: Adrenal suppression</p>
<p style="text-indent:-2em;margin-left:4em;">Gastrointestinal: Nausea, vomiting (on emergence from anesthesia)</p>
<p style="text-indent:-2em;margin-left:4em;">Local: Pain at injection site (30% to 80%)</p>
<p style="text-indent:-2em;margin-left:4em;">Neuromuscular &amp; skeletal: Musculoskeletal disease (transient skeletal movements)</p>
<p style="text-indent:-2em;margin-left:4em;">Ophthalmic: Nystagmus</p>
<p style="text-indent:-2em;margin-left:2em;">1% to 10%: Gastrointestinal: Hiccups</p>
<p style="text-indent:-2em;margin-left:2em;">&lt;1%, postmarketing, and/or case reports: Apnea, bradycardia, cardiac arrhythmia, decreased cortisol (decreased cortisol synthesis), hypertension, hyperventilation, hypotension, hypoventilation, laryngospasm, muscle spasm (masseter; Bozeman 2002), tachycardia</p></div>
<div class="block coi drugH1Div" id="F169124"><span class="drugH1">Contraindications</span>
<p style="text-indent:0em;display:inline">Hypersensitivity to etomidate or any component of the formulation</p></div>
<div class="block war drugH1Div" id="F169110"><span class="drugH1">Warnings/Precautions</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Concerns related to adverse effects:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Adrenal steroid production: Etomidate inhibits 11-B-hydroxylase, an enzyme important in adrenal steroid production. A single induction dose blocks the normal stress-induced increase in adrenal cortisol production for 6 to 8 hours, up to 24 hours in elderly and debilitated patients. Continuous infusion of etomidate for sedation in the ICU may increase mortality because patients may not be able to respond to stress. Administration by continuous infusion is not recommended by the manufacturer. No increase in mortality has been identified with a single dose for induction of anesthesia (McPhee 2013).</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Disease-related concerns:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Heart failure: In a scientific statement from the American Heart Association, etomidate has been determined to be an agent that may exacerbate underlying myocardial dysfunction (magnitude: moderate) (AHA [Page 2016]).</p>
<p style="text-indent:-2em;margin-left:4em;">• Renal impairment: Risk of toxicity is greater in patients with renal impairment; use with caution and monitor renal function.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Special populations:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Older adult: May induce cardiac depression in elderly patients, especially those with hypertension; may require lower doses.</p>
<p style="text-indent:-2em;margin-left:4em;">• Pediatric neurotoxicity: In pediatric and neonatal patients &lt;3 years and patients in third trimester of pregnancy (ie, times of rapid brain growth and synaptogenesis), the repeated or lengthy exposure to sedatives or anesthetics during surgery/procedures may have detrimental effects on child or fetal brain development and may contribute to various cognitive and behavioral problems. Epidemiological studies in humans have reported various cognitive and behavioral problems, including neurodevelopmental delay (and related diagnoses), learning disabilities, and ADHD. Human clinical data suggest that single, relatively short exposures are not likely to have similar negative effects. No specific anesthetic/sedative has been found to be safer. For elective procedures, risks versus benefits should be evaluated and discussed with parents/caregivers/patients; critical surgeries should not be delayed (FDA 2016).</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Other warnings/precautions:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Appropriate use: When considering use, weigh etomidate hemodynamic properties against the high frequency of transient skeletal muscle movements.</p>
<p style="text-indent:-2em;margin-left:4em;">• Experienced personnel: According to the manufacturer, etomidate should only be administered by experienced personnel trained in the administration of general anesthetics and in the management of complications encountered during the conduct of general anesthesia. Consult local regulations and individual institutional policies and procedures.</p></div>
<div class="block add-pediatric-warn-info drugH1Div" id="F52878450"><span class="drugH1">Warnings: Additional Pediatric Considerations</span>
<p style="text-indent:0em;display:inline">Adrenal suppression has been documented with etomidate use, even after a single dose. Cortisol concentrations decrease quickly after the induction dose, lasting up to 8 hours in healthy adults and up to 24 hours in pediatric surgical patients; however, 2 prospective pediatric studies have reported no adverse clinical outcomes due to the adrenal suppression (Du 2015; Gu 2015). However, a retrospective study of pediatric patients admitted for meningococcal sepsis found patients receiving a single etomidate dose for rapid sequence intubation (n=23) had significantly decreased cortisol concentrations for at least 24 hours, and higher ACTH and 11-deoxycortisol concentrations compared to those who did not receive etomidate. In this study, 8 patients died due to hemodynamic failure, 7 of whom had received etomidate. While the role of etomidate on mortality is unclear in these cases, weigh the risk versus benefit prior to use and if use deemed necessary use with caution (den Brinker 2008). Etomidate use is not recommended in pediatric patients with sepsis or septic shock (Brierley 2009; Dellinger 2013; PALS [Kleinman 2010]).</p>
<p style="text-indent:0em;margin-top:2em;">In pediatric and neonatal patients &lt;3 years of age and patients in third trimester of pregnancy (ie, times of rapid brain growth and synaptogenesis), the repeated or lengthy exposure to sedatives or anesthetics during surgery/procedures may have detrimental effects on the child's or fetus’ brain development and may contribute to various cognitive and behavioral problems; the FDA is requiring warnings be included in the manufacturer's labeling for all general anesthetic/sedative drugs. Multiple animal species studies have shown adverse effects on brain maturation; in juvenile animals, drugs that potentiate GABA activity and/or block NMDA receptors for &gt;3 hours demonstrated widespread neuronal and oligodendrocyte cell loss along with alteration in synaptic morphology and neurogenesis. Epidemiological studies in humans have reported various cognitive and behavioral problems including neurodevelopmental delay (and related diagnoses), learning disabilities, and attention-deficit/hyperactivity disorder. Human clinical data suggest that single, relatively short exposures are not likely to have similar negative effects. Further studies are needed to fully characterize findings and ensure that these findings are not related to underlying conditions or the procedure itself. No specific anesthetic/sedative has been found to be safer. For elective procedures, risk vs benefits should be evaluated and discussed with parents/caregivers/patients; critical surgeries should not be delayed (FDA 2016).</p>
<p style="text-indent:0em;margin-top:2em;">Some dosage forms may contain propylene glycol; in neonates, large amounts of propylene glycol delivered orally, intravenously (eg, &gt;3,000 mg/day), or topically have been associated with potentially fatal toxicities which can include metabolic acidosis, seizures, renal failure, and CNS depression; toxicities have also been reported in children and adults including hyperosmolality, lactic acidosis, seizures, and respiratory depression; use caution (AAP 1997; Shehab 2009).</p></div>
<div class="block foc drugH1Div" id="F169120"><span class="drugH1">Dosage Forms: US</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Solution, Intravenous: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Amidate: 2 mg/mL (10 mL, 20 mL) [contains propylene glycol]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 2 mg/mL (10 mL, 20 mL)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Solution, Intravenous [preservative free]: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 2 mg/mL (10 mL, 20 mL)</p></div>
<div class="block geq drugH1Div" id="F169106"><span class="drugH1">Generic Equivalent Available: US</span>
<p style="text-indent:0em;display:inline">Yes</p></div>
<div class="block fee drugH1Div" id="F16323138"><span class="drugH1">Pricing: US</span>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (Amidate Intravenous)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">2 mg/mL (per mL): $0.68</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (Etomidate Intravenous)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">2 mg/mL (per mL): $0.27 - $1.18</p>
<p style="text-indent:0em;">
<b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>
<div class="block dinfoc drugH1Div" id="F54870315"><span class="drugH1">Dosage Forms: Canada</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Solution, Intravenous: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Tomvi: 2 mg/mL (10 mL, 20 mL) [contains propylene glycol]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 2 mg/mL (11 mL, 20 mL)</p></div>
<div class="block adm drugH1Div" id="F2364901"><span class="drugH1">Administration: Adult</span>
<p style="text-indent:0em;display:inline">IV: Administer IV push over 30 to 60 seconds. Solution is highly irritating; avoid administration into small vessels; in some cases, preadministration of lidocaine may be considered.</p></div>
<div class="block admp drugH1Div" id="F52612786"><span class="drugH1">Administration: Pediatric</span>
<p style="text-indent:0em;display:inline">IV: Administer IV push over 30 to 60 seconds; very irritating; avoid administration into small vessels on the head or dorsum of the hand (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-1259886']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-1259886'])">Ref</a></span>); preadministration of lidocaine may be beneficial (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-18090099','lexi-content-ref-20502386']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-18090099','lexi-content-ref-20502386'])">Ref</a></span>).</p></div>
<div class="block use drugH1Div" id="F169121"><span class="drugH1">Use: Labeled Indications</span>
<p style="text-indent:0em;display:inline">
<b>General anesthesia:</b> Induction of general anesthesia; as a supplement to subpotent anesthetic agents during maintenance of anesthesia for short operative procedures (eg, rapid sequence intubation, dilation and curettage, cervical conization).</p></div>
<div class="block off-label drugH1Div" id="F25725533"><span class="drugH1">Use: Off-Label: Adult</span><p>Cushing syndrome; Procedural sedation</p></div>
<div class="block mst drugH1Div" id="F169171"><span class="drugH1">Medication Safety Issues</span>
<div class="collapsible">
<span class="collapsible-title">Sound-alike/look-alike issues: </span>
<div class="collapsible-wrap">
<p style="text-indent:-2em;margin-left:4em;">Etomidate may be confused with etidronate</p></div>
</div>
<div class="collapsible">
<span class="collapsible-title">High alert medication:</span>
<div class="collapsible-wrap">
<p style="text-indent:-2em;margin-left:4em;">The Institute for Safe Medication Practices (ISMP) includes this medication among its list of drugs which have a heightened risk of causing significant patient harm when used in error. </p></div>
</div>
</div>
<div class="block cyt drugH1Div" id="F13299304"><span class="drugH1">Metabolism/Transport Effects</span>
<p style="text-indent:0em;display:inline">None known.</p></div>
<div class="block dri drugH1Div" id="F169115"><span class="drugH1">Drug Interactions</span><br/><br/><div class="clear"></div><p xmlns=""></p><div class="inner" xmlns=""><p style="text-indent:0em;display:inline"><b>Note</b>: Interacting drugs may <b>not be individually listed below</b> if they are part of a group interaction (eg, individual drugs within “CYP3A4 Inducers [Strong]” are NOT listed).  For a complete list of drug interactions by individual drug name and detailed management recommendations, use the Lexicomp drug interactions program by clicking on the “Launch drug interactions program” link above.</p><p xmlns=""></p></div>
<p style="text-indent:-2em;margin-left:2em;">MetroNIDAZOLE (Systemic): May enhance the adverse/toxic effect of Products Containing Propylene Glycol. A disulfiram-like reaction may occur.<i> Risk X: Avoid combination</i></p>
<p style="text-indent:-2em;margin-left:2em;">Ornidazole: May enhance the adverse/toxic effect of Products Containing Propylene Glycol. Specifically, a disulfiram-like reaction may occur.<i> Risk X: Avoid combination</i></p>
<p style="text-indent:-2em;margin-left:2em;">Secnidazole: Products Containing Propylene Glycol may enhance the adverse/toxic effect of Secnidazole. <i> Risk X: Avoid combination</i></p></div>
<div class="block pri drugH1Div" id="F13763473"><span class="drugH1">Pregnancy Considerations</span>
<p style="text-indent:0em;">Etomidate crosses the placenta (Esener 1992; Gregory 1991).</p>
<p style="text-indent:0em;margin-top:2em;">Based on animal data, repeated or prolonged use of general anesthetic and sedation medications that block N-methyl-D-aspartate receptors and/or potentiate GABA activity may affect brain development. Evaluate benefits and potential risks of fetal exposure to etomidate when duration of surgery is expected to be &gt;3 hours (Olutoye 2018).</p>
<p style="text-indent:0em;margin-top:2em;">Use of etomidate for induction of anesthesia prior to cesarean delivery has been described (Downing 1979; Houlton 1978; Regaert 1984). However, other agents are more commonly used (ACOG 209 2019).</p>
<p style="text-indent:0em;margin-top:2em;">The ACOG recommends that pregnant women should not be denied medically necessary surgery, regardless of trimester. If the procedure is elective, it should be delayed until after delivery (ACOG 775 2019).</p></div>
<div class="block brc drugH1Div" id="F20617116"><span class="drugH1">Breastfeeding Considerations</span>
<p style="text-indent:-2em;margin-left:2em;">Etomidate is present in breast milk (Esener 1992).</p>
<p style="text-indent:-2em;margin-left:2em;">Following use of etomidate as an induction agent in 40 women undergoing cesarean delivery, etomidate was present in the colostrum at both 30 minutes and 2 hours after maternal injection. Etomidate was not present in breast milk 4 hours after the maternal dose (Esener 1992).</p>
<p style="text-indent:-2em;margin-left:2em;">The manufacturer recommends that caution be exercised when administering etomidate to breastfeeding females; however, use is considered acceptable (Dalal 2014). The Academy of Breast Feeding Medicine recommends postponing elective surgery until milk supply and breastfeeding are established. Milk should be expressed ahead of surgery when possible. In general, when the child is healthy and full term, breastfeeding may resume, or milk may be expressed once the mother is awake and in recovery. For children who are at risk for apnea, hypotension, or hypotonia, milk may be saved for later use when the child is at lower risk (ABM [Reece-Stremtan 2017]).</p></div>
<div class="block mop drugH1Div" id="F169118"><span class="drugH1">Monitoring Parameters</span>
<p style="text-indent:0em;display:inline">Cardiac monitoring; blood pressure; renal function (in renal impairment); for treatment of Cushing syndrome, monitor serum cortisol levels every 4 to 6 hours (ES [Nieman 2015]).</p></div>
<div class="block pha drugH1Div" id="F169109"><span class="drugH1">Mechanism of Action</span>
<p style="text-indent:0em;display:inline">Ultra-short-acting nonbarbiturate general anesthetic (benzylimidazole) used for rapid induction of anesthesia with minimal cardiovascular effects; produces EEG burst suppression at high doses. Decreases endogenous cortisol synthesis via inhibition of 11-beta-hydroxylase (Pence 2022).</p></div>
<div class="block phk drugH1Div" id="F169123"><span class="drugH1">Pharmacokinetics (Adult Data Unless Noted)</span>
<p style="text-indent:-2em;margin-left:2em;">Onset of action: 30 to 60 seconds</p>
<p style="text-indent:-2em;margin-left:4em;">Peak effect: 1 minute</p>
<p style="text-indent:-2em;margin-left:2em;">Duration: Dose dependent: 2 to 3 minutes (0.15 mg/kg dose); 3 to 5 minutes (0.3 mg/kg dose); rapid recovery is due to rapid redistribution</p>
<p style="text-indent:-2em;margin-left:2em;">Distribution: V<sub>d</sub>: 2 to 4.5 L/kg</p>
<p style="text-indent:-2em;margin-left:2em;">Protein binding: 76%; decreased protein binding resulting in an increased percentage of “free” etomidate in patients with renal failure or hepatic cirrhosis</p>
<p style="text-indent:-2em;margin-left:2em;">Metabolism: Hepatic and plasma esterases</p>
<p style="text-indent:-2em;margin-left:2em;">Half-life elimination: Terminal: 2.6 to 3.5 hours</p>
<p style="text-indent:-2em;margin-left:2em;">Time to peak, serum: 7 minutes</p>
<p style="text-indent:-2em;margin-left:2em;">Excretion: Urine ~75% (80% as metabolite; 2% as unchanged drug)</p></div>
<div class="block phksp drugH1Div" id="F51154115"><span class="drugH1">Pharmacokinetics: Additional Considerations (Adult Data Unless Noted)</span>
<p style="text-indent:-2em;margin-left:2em;">Hepatic function impairment: V<sub>d</sub> and elimination half-life increase 2-fold in patients with cirrhosis compared with healthy subjects.</p>
<p style="text-indent:-2em;margin-left:2em;">Older adult: V<sub>d</sub>, total clearance, and plasma protein binding are decreased in elderly patients.</p></div>
<div class="list fbnlist drugH1Div drugBrandNames" id="F169126"><span class="drugH1">Brand Names: International</span><div class="ibn-search drugBrandNames"></div>
<div class="collapsible-indication brand-names-accordion drugBrandNames"><span class="collapsible-indication-title">International Brand Names by Country</span><div class="collapsible-indication-wrap-frame drugBrandNames"><div class="collapsible-indication-wrap drugBrandNames">For country code abbreviations (<a class="graphic graphic_table" href="/d/html/116421.html" rel="external">show table</a>)<br xmlns=""/><br/><ul>
<li>
<span class="countryCode">(AE)</span> <span class="country">United Arab Emirates</span><span class="countrySeparator">: </span><span class="drugName">Etomidate lipuro</span>;</li>
<li>
<span class="countryCode">(AR)</span> <span class="country">Argentina</span><span class="countrySeparator">: </span><span class="drugName">Midatus</span>;</li>
<li>
<span class="countryCode">(AT)</span> <span class="country">Austria</span><span class="countrySeparator">: </span><span class="drugName">Etomidat lipuro | Hypnomidate</span>;</li>
<li>
<span class="countryCode">(BE)</span> <span class="country">Belgium</span><span class="countrySeparator">: </span><span class="drugName">Etomidate Braun Pharma | Etomidate lipuro | Hypnomidate</span>;</li>
<li>
<span class="countryCode">(BG)</span> <span class="country">Bulgaria</span><span class="countrySeparator">: </span><span class="drugName">Hypnomidate</span>;</li>
<li>
<span class="countryCode">(BR)</span> <span class="country">Brazil</span><span class="countrySeparator">: </span><span class="drugName">Etomidato | Hypnomidate</span>;</li>
<li>
<span class="countryCode">(CN)</span> <span class="country">China</span><span class="countrySeparator">: </span><span class="drugName">Etomidate lipuro | Fu er li</span>;</li>
<li>
<span class="countryCode">(CO)</span> <span class="country">Colombia</span><span class="countrySeparator">: </span><span class="drugName">Endatal | Etomidato Lipuro | Troymidate</span>;</li>
<li>
<span class="countryCode">(CZ)</span> <span class="country">Czech Republic</span><span class="countrySeparator">: </span><span class="drugName">Hypnomidate | Radenarcon</span>;</li>
<li>
<span class="countryCode">(DE)</span> <span class="country">Germany</span><span class="countrySeparator">: </span><span class="drugName">Etomidat lipuro | Hypnomidate | Radenarcon</span>;</li>
<li>
<span class="countryCode">(EC)</span> <span class="country">Ecuador</span><span class="countrySeparator">: </span><span class="drugName">Etomidato Lipuro</span>;</li>
<li>
<span class="countryCode">(EE)</span> <span class="country">Estonia</span><span class="countrySeparator">: </span><span class="drugName">Etomidat lipuro | Hypnomidate</span>;</li>
<li>
<span class="countryCode">(ES)</span> <span class="country">Spain</span><span class="countrySeparator">: </span><span class="drugName">Etomidato Lipuro | Hypnomidate | Sibul</span>;</li>
<li>
<span class="countryCode">(FR)</span> <span class="country">France</span><span class="countrySeparator">: </span><span class="drugName">Etomidate lipuro | Hypnomidate</span>;</li>
<li>
<span class="countryCode">(GB)</span> <span class="country">United Kingdom</span><span class="countrySeparator">: </span><span class="drugName">Etomidate lipuro | Hypnomidate</span>;</li>
<li>
<span class="countryCode">(GR)</span> <span class="country">Greece</span><span class="countrySeparator">: </span><span class="drugName">Hypnomidate</span>;</li>
<li>
<span class="countryCode">(HU)</span> <span class="country">Hungary</span><span class="countrySeparator">: </span><span class="drugName">Etomidat lipuro</span>;</li>
<li>
<span class="countryCode">(ID)</span> <span class="country">Indonesia</span><span class="countrySeparator">: </span><span class="drugName">Etomidate lipuro</span>;</li>
<li>
<span class="countryCode">(IN)</span> <span class="country">India</span><span class="countrySeparator">: </span><span class="drugName">Troymidate</span>;</li>
<li>
<span class="countryCode">(KR)</span> <span class="country">Korea, Republic of</span><span class="countrySeparator">: </span><span class="drugName">Etomidate lipuro</span>;</li>
<li>
<span class="countryCode">(KW)</span> <span class="country">Kuwait</span><span class="countrySeparator">: </span><span class="drugName">Etomidate lipuro</span>;</li>
<li>
<span class="countryCode">(LB)</span> <span class="country">Lebanon</span><span class="countrySeparator">: </span><span class="drugName">Hypnomidate</span>;</li>
<li>
<span class="countryCode">(LT)</span> <span class="country">Lithuania</span><span class="countrySeparator">: </span><span class="drugName">Etomidate lipuro | Hypnomidate</span>;</li>
<li>
<span class="countryCode">(LU)</span> <span class="country">Luxembourg</span><span class="countrySeparator">: </span><span class="drugName">Etomidat lipuro</span>;</li>
<li>
<span class="countryCode">(LV)</span> <span class="country">Latvia</span><span class="countrySeparator">: </span><span class="drugName">Etomidate lipuro | Hypnomidate</span>;</li>
<li>
<span class="countryCode">(MA)</span> <span class="country">Morocco</span><span class="countrySeparator">: </span><span class="drugName">Hypnomidate</span>;</li>
<li>
<span class="countryCode">(MX)</span> <span class="country">Mexico</span><span class="countrySeparator">: </span><span class="drugName">Endatal | Etomidato | Hypnomidate</span>;</li>
<li>
<span class="countryCode">(MY)</span> <span class="country">Malaysia</span><span class="countrySeparator">: </span><span class="drugName">Etomidate lipuro</span>;</li>
<li>
<span class="countryCode">(NL)</span> <span class="country">Netherlands</span><span class="countrySeparator">: </span><span class="drugName">Etomidaat-lipuro | Hypnomidate</span>;</li>
<li>
<span class="countryCode">(NO)</span> <span class="country">Norway</span><span class="countrySeparator">: </span><span class="drugName">Hypnomidate</span>;</li>
<li>
<span class="countryCode">(NZ)</span> <span class="country">New Zealand</span><span class="countrySeparator">: </span><span class="drugName">Etomidate lipuro | Hypnomidate</span>;</li>
<li>
<span class="countryCode">(PK)</span> <span class="country">Pakistan</span><span class="countrySeparator">: </span><span class="drugName">Etomidate lipuro</span>;</li>
<li>
<span class="countryCode">(PL)</span> <span class="country">Poland</span><span class="countrySeparator">: </span><span class="drugName">Etomidate lipuro | Hypnomidate | Radenarcon</span>;</li>
<li>
<span class="countryCode">(PR)</span> <span class="country">Puerto Rico</span><span class="countrySeparator">: </span><span class="drugName">Amidate</span>;</li>
<li>
<span class="countryCode">(PT)</span> <span class="country">Portugal</span><span class="countrySeparator">: </span><span class="drugName">Etomidato Lipuro | Hypnomidato</span>;</li>
<li>
<span class="countryCode">(RO)</span> <span class="country">Romania</span><span class="countrySeparator">: </span><span class="drugName">Etomidat lipuro</span>;</li>
<li>
<span class="countryCode">(SG)</span> <span class="country">Singapore</span><span class="countrySeparator">: </span><span class="drugName">Etomidate lipuro</span>;</li>
<li>
<span class="countryCode">(SI)</span> <span class="country">Slovenia</span><span class="countrySeparator">: </span><span class="drugName">Etomidat lipuro | Hypnomidate</span>;</li>
<li>
<span class="countryCode">(SK)</span> <span class="country">Slovakia</span><span class="countrySeparator">: </span><span class="drugName">Hypnomidate</span>;</li>
<li>
<span class="countryCode">(TH)</span> <span class="country">Thailand</span><span class="countrySeparator">: </span><span class="drugName">Etomidate Braun Pharma | Etomidate lipuro | Hypnomidate</span>;</li>
<li>
<span class="countryCode">(TN)</span> <span class="country">Tunisia</span><span class="countrySeparator">: </span><span class="drugName">Hypnomidate</span>;</li>
<li>
<span class="countryCode">(TR)</span> <span class="country">Turkey</span><span class="countrySeparator">: </span><span class="drugName">Etomidate lipuro | Hypnomidate</span>;</li>
<li>
<span class="countryCode">(TW)</span> <span class="country">Taiwan</span><span class="countrySeparator">: </span><span class="drugName">Etomidate Braun Pharma | Hypnomidate</span>;</li>
<li>
<span class="countryCode">(UY)</span> <span class="country">Uruguay</span><span class="countrySeparator">: </span><span class="drugName">Etomidato | Etomidato cristalia | Hypnomidate</span>;</li>
<li>
<span class="countryCode">(ZA)</span> <span class="country">South Africa</span><span class="countrySeparator">: </span><span class="drugName">Hypnomidate</span>;</li>
<li>
<span class="countryCode">(ZW)</span> <span class="country">Zimbabwe</span><span class="countrySeparator">: </span><span class="drugName">Hypnomidate</span></li></ul></div>
</div>
</div>
</div>
</div><div class="headingAnchor" id="references"><ol id="reference">
<li>
<div class="reference" id="lexi-content-ref-21252774">
<a name="21252774"></a>ACOG Committee on Obstetric Practice (ACOG). ACOG Committee Opinion No. 474: Nonobstetric surgery during pregnancy. <i>Obstet Gynecol</i>. 2011;117(2, pt 1):420-421. doi:10.1097/AOG.0b013e31820eede9.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/etomidate-drug-information/abstract-text/21252774/pubmed" id="21252774" target="_blank">21252774</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-9024461">
<a name="9024461"></a>American Academy of Pediatrics Committee on Drugs. "Inactive" ingredients in pharmaceutical products: update (subject review). <i>Pediatrics</i>. 1997;99(2):268-278.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/etomidate-drug-information/abstract-text/9024461/pubmed" id="9024461" target="_blank">9024461</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-30913200">
<a name="30913200"></a>American College of Obstetricians and Gynecologists (ACOG). ACOG Committee Opinion No. 775: Nonobstetric surgery during pregnancy. <i>Obstet Gynecol</i>. 2019;133(4):e285-e286.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/etomidate-drug-information/abstract-text/30913200/pubmed" id="30913200" target="_blank">30913200</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-30801474">
<a name="30801474"></a>American College of Obstetricians and Gynecologists (ACOG). ACOG Practice Bulletin No. 209: Obstetric analgesia and anesthesia. <i>Obstet Gynecol</i>. 2019;133(3):e208-e225.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/etomidate-drug-information/abstract-text/30801474/pubmed" id="30801474" target="_blank">30801474</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Amidate.1">
<a name="Amidate.1"></a>Amidate injection (etomidate) [prescribing information]. Lake Forest, IL: Hospira Inc; April 2022.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-15829394">
<a name="15829394"></a>Bahn EL, Holt KR. Procedural Sedation and Analgesia: A Review and New Concepts. <i>Emerg Med Clin North Am</i>. 2005;23(2):503-517.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/etomidate-drug-information/abstract-text/15829394/pubmed" id="15829394" target="_blank">15829394</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-18090099">
<a name="18090099"></a>Baxter AL, Mallory MD, Spandorfer PR, et al. Etomidate versus pentobarbital for computed tomography sedations: report from the Pediatric Sedation Research Consortium. <i>Pediatr Emerg Care</i>. 2007;23(10):690-695.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/etomidate-drug-information/abstract-text/18090099/pubmed" id="18090099" target="_blank">18090099</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-12087322">
<a name="12087322"></a>Bozeman WP, Young S. Etomidate as a sole agent for endotracheal intubation in the prehospital air medical setting. <i>Air Med J</i>. 2002;21(4):32-55.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/etomidate-drug-information/abstract-text/12087322/pubmed" id="12087322" target="_blank">12087322</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-19325359">
<a name="19325359"></a>Brierley J, Carcillo JA, Choong K, et al. Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine. <i>Crit Care Med</i>. 2009;37(2):666-688.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/etomidate-drug-information/abstract-text/19325359/pubmed" id="19325359" target="_blank">19325359</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-30560224">
<a name="30560224"></a>Carroll TB, Peppard WJ, Herrmann DJ, et al. Continuous etomidate infusion for the management of severe Cushing syndrome: validation of a standard protocol. <i>J Endocr Soc</i>. 2018;3(1):1-12. doi:10.1210/js.2018-00269<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/etomidate-drug-information/abstract-text/30560224/pubmed" id="30560224" target="_blank">30560224</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-24372776">
<a name="24372776"></a>Dalal PG, Bosak J, Berlin C. Safety of the breast-feeding infant after maternal anesthesia. <i>Paediatr Anaesth</i>. 2014;24(4):359-371. doi:10.1111/pan.12331<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/etomidate-drug-information/abstract-text/24372776/pubmed" id="24372776" target="_blank">24372776</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-23361625">
<a name="23361625"></a>Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. <i>Intensive Care Med</i>. 2013;39(2):165-228.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/etomidate-drug-information/abstract-text/23361625/pubmed" id="23361625" target="_blank">23361625</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-17710382">
<a name="17710382"></a>den Brinker M, Hokken-Koelega AC, Hazelzet JA, de Jong FH, Hop WC, Joosten KF. One single dose of etomidate negatively influences adrenocortical performance for at least 24h in children with meningococcal sepsis. <i>Intensive Care Med</i>. 2008;34(1):163-168.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/etomidate-drug-information/abstract-text/17710382/pubmed" id="17710382" target="_blank">17710382</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-11136155">
<a name="11136155"></a>Dickinson R, Singer AJ, Carrion W. Etomidate for pediatric sedation prior to fracture reduction. <i>Acad Emerg Med</i>. 2001;8(1):74-77.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/etomidate-drug-information/abstract-text/11136155/pubmed" id="11136155" target="_blank">11136155</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-16997680">
<a name="16997680"></a>Di Liddo L, D'Angelo A, Nguyen B, Bailey B, Amre D, Stanciu C. Etomidate versus midazolam for procedural sedation in pediatric outpatients: a randomized controlled trial. <i>Ann Emerg Med</i>. 2006;48(4):433-440, 440.e1.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/etomidate-drug-information/abstract-text/16997680/pubmed" id="16997680" target="_blank">16997680</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-11973219">
<a name="11973219"></a>Ding Z and White PF, “Anesthesia for Electroconvulsive Therapy,” <i>Anesth Analg</i>, 2002, 94(5):1351-64.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/etomidate-drug-information/abstract-text/11973219/pubmed" id="11973219" target="_blank">11973219</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-426990">
<a name="426990"></a>Downing JW, Buley RJ, Brock-Utne JG, Houlton PC. Etomidate for induction of anaesthesia at caesarean section: comparison with thiopentone. <i>Br J Anaesth</i>. 1979;51(2):135-140.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/etomidate-drug-information/abstract-text/426990/pubmed" id="426990" target="_blank">426990</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-26496368">
<a name="26496368"></a>Du Y, Chen YJ, He B, Wang YW. The Effects of Single-Dose Etomidate Versus Propofol on Cortisol Levels in Pediatric Patients Undergoing Urologic Surgery: A Randomized Controlled Trial. <i>Anesth Analg</i>. 2015;121(6):1580-1585.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/etomidate-drug-information/abstract-text/26496368/pubmed" id="26496368" target="_blank">26496368</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-37196592">
<a name="37196592"></a>Engstrom K, Brown CS, Mattson AE, Lyons N, Rech MA. Pharmacotherapy optimization for rapid sequence intubation in the emergency department. <i>Am J Emerg Med.</i> 2023;70:19-29. doi:10.1016/j.ajem.2023.05.004<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/etomidate-drug-information/abstract-text/37196592/pubmed" id="37196592" target="_blank">37196592</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-32513237">
<a name="32513237"></a>Erstad BL, Barletta JF. Drug dosing in the critically ill obese patient-a focus on sedation, analgesia, and delirium. <i>Crit Care</i>. 2020;24(1):315. doi:10.1186/s13054-020-03040-z<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/etomidate-drug-information/abstract-text/32513237/pubmed" id="32513237" target="_blank">32513237</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-1467101">
<a name="1467101"></a>Esener Z, Sarihasan B, Güven H, Ustün E. Thiopentone and etomidate concentrations in maternal and umbilical plasma, and in colostrum. <i>Br J Anaesth</i>. 1992;69(6):586-588.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/etomidate-drug-information/abstract-text/1467101/pubmed" id="1467101" target="_blank">1467101</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Expert.DOO">
<a name="Expert.DOO"></a>Expert opinion. Senior Obesity EditorialTeam: Jeffrey F. Barletta, PharmD, FCCM; Manjunath P. Pai, PharmD, FCP; Jason A. Roberts, PhD,BPharm (Hons), B App Sc, FSHP, FISAC.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-15173551">
<a name="15173551"></a>Falk J, Zed PJ. Etomidate for Procedural Sedation in the Emergency Department. <i>Ann Pharmacother</i>. 2004;38(7-8):1272-1277.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/etomidate-drug-information/abstract-text/15173551/pubmed" id="15173551" target="_blank">15173551</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-25101716">
<a name="25101716"></a>Gaszynski TM, Jakubiak J, Szewczyk T. Etomidate can be dosed according to ideal body weight in morbidly obese patients.<i> Eur J Anaesthesiol</i>. 2014;31(12):713-714. doi:10.1097/EJA.0000000000000141<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/etomidate-drug-information/abstract-text/25101716/pubmed" id="25101716" target="_blank">25101716</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Ghazal.1">
<a name="Ghazal.1"></a>Ghazal EA, Vadi MG, Mason LJ, Coté CJ. Preoperative evaluation, premedication, and induction of anesthesia. In: Coté CJ, Lerman J, Anderson B, eds. <i>A Practice of Anesthesia for Infants and Children</i>. 6th ed. Elsevier; 2019:chap. 4.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-24438649">
<a name="24438649"></a>Godwin SA, Burton JH, Gerardo CJ, et al; American College of Emergency Physicians. Clinical policy: procedural sedation and analgesia in the emergency department. <i>Ann Emerg Med</i>. 2014;63(2):247-258.e18. doi:10.1016/j.annemergmed.2013.10.015<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/etomidate-drug-information/abstract-text/24438649/pubmed" id="24438649" target="_blank">24438649</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-1928667">
<a name="1928667"></a>Gregory MA, Davidson DG. Plasma etomidate levels in mother and fetus. <i>Anaesthesia</i>. 1991;46(9):716-718.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/etomidate-drug-information/abstract-text/1928667/pubmed" id="1928667" target="_blank">1928667</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-26022508">
<a name="26022508"></a>Gu H, Zhang M, Cai M, Liu J. Comparison of Adrenal Suppression between Etomidate and Dexmedetomidine in Children with Congenital Heart Disease. <i>Med Sci Monit</i>. 2015;21:1569-1576.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/etomidate-drug-information/abstract-text/26022508/pubmed" id="26022508" target="_blank">26022508</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Hazinski.1">
<a name="Hazinski.1"></a>Hazinski MF, Shuster M, Donnino MW, et al.<i> 2015 Handbook of Emergency Cardiovascular Care for Healthcare Providers</i>. American Heart Association; 2015.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-18784570">
<a name="18784570"></a>Hildreth AN, Mejia VA, Maxwell RA, et al. Adrenal Suppression Following a Single Dose of Etomidate for Rapid Sequence Induction: A Prospective Randomized Study. <i>J Trauma</i>. 2008;65(3):573-579.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/etomidate-drug-information/abstract-text/18784570/pubmed" id="18784570" target="_blank">18784570</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-741308">
<a name="741308"></a>Houlton PJ, Downing JW, Buley RJ, Brock-Utne JG. Anaesthetic induction for caesarean section with etomidate compared with thiopentone. <i>S Afr Med J</i>. 1978;4;54(19):773-775.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/etomidate-drug-information/abstract-text/741308/pubmed" id="741308" target="_blank">741308</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-32193044">
<a name="32193044"></a>Hu Y, Yang XY, Zhang JH. Etomidate plus fentanyl for anesthesia in pediatric strabotomy. <i>Med Hypotheses</i>. Published online March 6, 2020. doi:10.1016/j.mehy.2020.109666<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/etomidate-drug-information/abstract-text/32193044/pubmed" id="32193044" target="_blank">32193044</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-19573904">
<a name="19573904"></a>Jabre P, Combes X, Lapostolle F, et al; KETASED Collaborative Study Group. Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trial. <i>Lancet</i>. 2009;374(9686):293-300. doi:10.1016/S0140-6736(09)60949-1<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/etomidate-drug-information/abstract-text/19573904/pubmed" id="19573904" target="_blank">19573904</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-20498288">
<a name="20498288"></a>Kaneda K, Yamashita S, Woo S, Han TH. Population pharmacokinetics and pharmacodynamics of brief etomidate infusion in healthy volunteers. <i>J Clin Pharmacol</i>. 2011;51(4):482-491. doi:10.1177/0091270010369242<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/etomidate-drug-information/abstract-text/20498288/pubmed" id="20498288" target="_blank">20498288</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-1259886">
<a name="1259886"></a>Kay B. A clinical assessment of the use of etomidate in children. <i>Br J Anaesth</i>. 1976;48(3):207-211.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/etomidate-drug-information/abstract-text/1259886/pubmed" id="1259886" target="_blank">1259886</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-15295244">
<a name="15295244"></a>Kienstra AJ, Ward MA, Sasan F, et al. Etomidate Versus Pentobarbital for Sedation of Children for Head and Neck CT Imaging. <i>Pediatr Emerg Care</i>. 2004;20(8):499-506.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/etomidate-drug-information/abstract-text/15295244/pubmed" id="15295244" target="_blank">15295244</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-37248552">
<a name="37248552"></a>Kim J, Jung K, Moon J, et al. Ketamine versus etomidate for rapid sequence intubation in patients with trauma: a retrospective study in a level 1 trauma center in Korea. <i>BMC Emerg Med.</i> 2023;23(1):57. doi:10.1186/s12873-023-00833-7<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/etomidate-drug-information/abstract-text/37248552/pubmed" id="37248552" target="_blank">37248552</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-20956230">
<a name="20956230"></a>Kleinman ME, Chameides L, Schexnayder SM, et al. Part 14: pediatric advanced life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. <i>Circulation</i>. 2010;122(18)(suppl 3):S876-908.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/etomidate-drug-information/abstract-text/20956230/pubmed" id="20956230" target="_blank">20956230</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-20502386">
<a name="20502386"></a>Lee-Jayaram JJ, Green A, Siembieda J, et al. Ketamine/midazolam versus etomidate/fentanyl: procedural sedation for pediatric orthopedic reductions. <i>Pediatr Emerg Care</i>. 2010;26(6):408-412.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/etomidate-drug-information/abstract-text/20502386/pubmed" id="20502386" target="_blank">20502386</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-21917057">
<a name="21917057"></a>Lin L, Zhang JW, Huang Y, Bai J, Cai MH, Zhang MZ. Population pharmacokinetics of intravenous bolus etomidate in children over 6 months of age. <i>Paediatr Anaesth</i>. 2012;22(4):318-326.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/etomidate-drug-information/abstract-text/21917057/pubmed" id="21917057" target="_blank">21917057</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-22929142">
<a name="22929142"></a>Mandt MJ, Roback MG, Bajaj L, Galinkin JL, Gao D, Wathen JE. Etomidate for short pediatric procedures in the emergency department. <i>Pediatr Emerg Care</i>. 2012;28(9):898-904.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/etomidate-drug-information/abstract-text/22929142/pubmed" id="22929142" target="_blank">22929142</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-34904190">
<a name="34904190"></a>Matchett G, Gasanova I, Riccio CA, et al; EvK Clinical Trial Collaborators. Etomidate versus ketamine for emergency endotracheal intubation: a randomized clinical trial. <i>Intensive Care Med</i>. 2022;48(1):78-91. doi:10.1007/s00134-021-06577-x<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/etomidate-drug-information/abstract-text/34904190/pubmed" id="34904190" target="_blank">34904190</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-23318491">
<a name="23318491"></a>McPhee LC, Badawi O, Fraser GL, et al. Single-dose etomidate is not associated with increased mortality in ICU patients with sepsis: analysis of a large electronic ICU database. <i>Crit Care Med</i>. 2013;41(3):774-783.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/etomidate-drug-information/abstract-text/23318491/pubmed" id="23318491" target="_blank">23318491</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-16997421">
<a name="16997421"></a>Miner JR, Danahy M, Moch A, et al. Randomized Clinical Trial of Etomidate Versus Propofol for Procedural Sedation in the Emergency Department. <i>Ann Emerg Med</i>. 2007;49(1):15-22.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/etomidate-drug-information/abstract-text/16997421/pubmed" id="16997421" target="_blank">16997421</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-26222757">
<a name="26222757"></a>Nieman LK, Biller BM, Findling JW, et al; Endocrine Society (ES). Treatment of Cushing's syndrome: an Endocrine Society clinical practice guideline. <i>J Clin Endocrinol Metab</i>. 2015;100(8):2807-2831. doi:10.1210/jc.2015-1818<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/etomidate-drug-information/abstract-text/26222757/pubmed" id="26222757" target="_blank">26222757</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-28888583">
<a name="28888583"></a>Olutoye OA, Baker BW, Belfort MA, Olutoye OO. Food and Drug Administration warning on anesthesia and brain development: implications for obstetric and fetal surgery. <i>Am J Obstet Gynecol</i>. 2018;218(1):98-102.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/etomidate-drug-information/abstract-text/28888583/pubmed" id="28888583" target="_blank">28888583</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-27400984">
<a name="27400984"></a>Page RL 2nd, O'Bryant CL, Cheng D, et al; American Heart Association Clinical Pharmacology and Heart Failure and Transplantation Committees of the Council on Clinical Cardiology; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular and Stroke Nursing; and Council on Quality of Care and Outcomes Research. Drugs That May Cause or Exacerbate Heart Failure: A Scientific Statement From the American Heart Association [published correction appears in <i>Circulation</i>. 2016;134(12):e261]. <i>Circulation</i>. 2016;134(6):e32-e69.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/etomidate-drug-information/abstract-text/27400984/pubmed" id="27400984" target="_blank">27400984</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-35186251">
<a name="35186251"></a>Pence A, McGrath M, Lee SL, Raines DE. Pharmacological management of severe Cushing's syndrome: the role of etomidate. <i>Ther Adv Endocrinol Metab</i>. 2022;13:20420188211058583. doi:10.1177/20420188211058583<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/etomidate-drug-information/abstract-text/35186251/pubmed" id="35186251" target="_blank">35186251</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-22577107">
<a name="22577107"></a>Preda VA, Sen J, Karavitaki N, Grossman AB. Etomidate in the management of hypercortisolaemia in Cushing's syndrome: a review. <i>Eur J Endocrinol</i>. 2012;167(2):137-143. doi:10.1530/EJE-12-0274<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/etomidate-drug-information/abstract-text/22577107/pubmed" id="22577107" target="_blank">22577107</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-29624435">
<a name="29624435"></a>Reece-Stremtan S, Campos M, Kokajko L; Academy of Breastfeeding Medicine. ABM clinical protocol #15: analgesia and anesthesia for the breastfeeding mother, revised 2017. <i>Breastfeed Med</i>. 2017;12(9):500-506.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/etomidate-drug-information/abstract-text/29624435/pubmed" id="29624435" target="_blank">29624435</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-6441435">
<a name="6441435"></a>Regaert P, Noorduin H. General anesthesia with etomidate, alfentanil and droperidol for caesarean section. <i>Acta Anaesthesiol Belg</i>. 1984;35(3):193-200.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/etomidate-drug-information/abstract-text/6441435/pubmed" id="6441435" target="_blank">6441435</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-26926332">
<a name="26926332"></a>Roback MG, Carlson DW, Babl FE, Kennedy RM. Update on pharmacological management of procedural sedation for children. <i>Curr Opin Anaesthesiol</i>. 2016;29(suppl 1):S21-S35. doi:10.1097/ACO.0000000000000316<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/etomidate-drug-information/abstract-text/26926332/pubmed" id="26926332" target="_blank">26926332</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-19188870">
<a name="19188870"></a>Shehab N, Lewis CL, Streetman DD, Donn SM. Exposure to the pharmaceutical excipients benzyl alcohol and propylene glycol among critically ill neonates. <i>Pediatr Crit Care Med</i>. 2009;10(2):256-259.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/etomidate-drug-information/abstract-text/19188870/pubmed" id="19188870" target="_blank">19188870</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-31871244">
<a name="31871244"></a>Shenoi RP, Timm N; Committee on Drugs; Committee on Pediatric Emergency Medicine. Drugs used to treat pediatric emergencies. <i>Pediatrics</i>. 2020;145(1):e20193450. doi:10.1542/peds.2019-3450<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/etomidate-drug-information/abstract-text/31871244/pubmed" id="31871244" target="_blank">31871244</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-37076524">
<a name="37076524"></a>Srivilaithon W, Bumrungphanithaworn A, Daorattanachai K, et al. Clinical outcomes after a single induction dose of etomidate versus ketamine for emergency department sepsis intubation: a randomized controlled trial. <i>Sci Rep</i>. 2023;13(1):6362. doi:10.1038/s41598-023-33679-x<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/etomidate-drug-information/abstract-text/37076524/pubmed" id="37076524" target="_blank">37076524</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-34535237">
<a name="34535237"></a>Stanke L, Nakajima S, Zimmerman LH, Collopy K, Fales C, Powers W 4th. Hemodynamic effects of ketamine versus etomidate for prehospital rapid sequence intubation. <i>Air Med J.</i> 2021;40(5):312-316. doi:10.1016/j.amj.2021.05.009<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/etomidate-drug-information/abstract-text/34535237/pubmed" id="34535237" target="_blank">34535237</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-25377074">
<a name="25377074"></a>Su F, El-Komy MH, Hammer GB, Frymoyer A, Cohane CA, Drover DR. Population pharmacokinetics of etomidate in neonates and infants with congenital heart disease. <i>Biopharm Drug Dispos</i>. 2015;36(2):104-114.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/etomidate-drug-information/abstract-text/25377074/pubmed" id="25377074" target="_blank">25377074</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-27993308">
<a name="27993308"></a>Upchurch CP, Grijalva CG, Russ S, et al. Comparison of etomidate and ketamine for induction during rapid sequence intubation of adult trauma patients. <i>Ann Emerg Med</i>. 2017;69(1):24-33.e2. doi:10.1016/j.annemergmed.2016.08.009<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/etomidate-drug-information/abstract-text/27993308/pubmed" id="27993308" target="_blank">27993308</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-FDA.1">
<a name="FDA.1"></a>US Food and Drug Administration (FDA). FDA Drug Safety Communication: FDA review results in new warnings about using general anesthetics and sedation drugs in young children and pregnant women. US Food and Drug Administration Web site. <a href="https://www.fda.gov/Drugs/DrugSafety/ucm532356.htm" target="_blank">https://www.fda.gov/Drugs/DrugSafety/ucm532356.htm</a>. Updated December 14, 2016. Accessed May 26, 2017.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-12023700">
<a name="12023700"></a>Vinson DR, Bradbury DR. Etomidate for procedural sedation in emergency medicine. <i>Ann Emerg Med</i>. 2002;39(6):592-598. doi:10.1067/mem.2002<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/etomidate-drug-information/abstract-text/12023700/pubmed" id="12023700" target="_blank">12023700</a>]</span>
</div>
</li></ol></div><div id="topicVersionRevision">Topic 8428 Version 297.0</div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
